Sign up to save your podcasts
Or
Share H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022.
Read the Study
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022.
Read the Study
More shows like Neuro-Oncology: The Podcast
View all
Planet Money
30,756 Listeners
Hidden Brain
43,653 Listeners
Global News Podcast
7,640 Listeners
The Gray Area with Sean Illing
10,726 Listeners
NEJM This Week
317 Listeners
Mayo Clinic Talks
296 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
The Daily
111,929 Listeners
Up First from NPR
56,595 Listeners
Today, Explained
10,220 Listeners
The Peter Attia Drive
8,512 Listeners
Hard Fork
5,526 Listeners
The Ezra Klein Show
15,867 Listeners
New Heights with Jason & Travis Kelce
18,128 Listeners
Not Gonna Lie with Kylie Kelce
10,148 Listeners